Uterine fibroid

• AbbVie

  Company6 trialsPhase 32,544 people

• Myovant Sciences

  Company4 trialsPhase 31,476 people

• PregLem

  Company2 trialsPhase 3341 people

• Qilu Pharmaceutical

  Company1 trialPhase 3120 people

• Repros Therapeutics

  Company1 trialPhase 377 people

• Peking Union Medical College Hospital

  1 trialPhase 425 people

• Northwestern University

  1 trialPhase 423 people

• University of California, San Francisco

  1 trialPhase 412 people

National Institute of Child Health and Human DevelopmentUS$2.4mNational Heart, Lung, and Blood InstituteUS$49.5k

• Effects of Surgical Removal of Uterine Fibroids on Atherosclerotic Cardiovascular Disease

  National Heart, Lung, and Blood InstituteUniversity of PennsylvaniaUS$49.5k2025–2026

• Role of senescent cells in uterine fibroid pathogenesis

  National Institute of Child Health and Human DevelopmentJohns Hopkins UniversityUS$791.6k2023–2027